Md. Code Regs. 10.09.69.17
ICD10 | ICD 10 Description | Age Limit |
B20 | Human immunodeficiency virus (HIV) disease | 0-20 |
C96.0 | Multifocal and multisystemic Langerhans-cell histiocytosis | 0-64 |
C96.5 | Multifocal and unisystemic Langerhans-cell histiocytosis | 0-64 |
C96.6 | Unifocal Langerhans-cell histiocytosis | 0-64 |
D61.01 | Constitutional (pure) red blood cell aplasia | 0-20 |
D61.09 | Other constitutional aplastic anemia | 0-20 |
D66 | Hereditary factor VIII deficiency | 0-64 |
D67 | Hereditary factor IX deficiency | 0-64 |
D68.00 | Von Willebrand disease, unspecified | 0-64 |
D68.01 | Von Willebrand disease, type 1 | 0-64 |
D68.020 | Von Willebrand disease, type 2A | 0-64 |
D68.021 | Von Willebrand disease, type 2B | 0-64 |
D68.022 | Von Willebrand disease, type 2M | 0-64 |
D68.023 | Von Willebrand disease, type 2N | 0-64 |
D68.029 | Von Willebrand disease, type 2, unspecified | 0-64 |
D68.03 | Von Willebrand disease, type 3 | 0-64 |
D68.04 | Acquired von Willebrand disease | 0-64 |
D68.09 | Other von Willebrand disease | 0-64 |
D68.1 | Hereditary factor XI deficiency | 0-64 |
D68.2 | Hereditary deficiency of other clotting factors | 0-64 |
E70.0 | Classical phenylketonuria | 0-20 |
E70.1 | Other hyperphenylalaninemias | 0-20 |
E70.20 | Disorder of tyrosine metabolism, unspecified | 0-20 |
E70.21 | Tyrosinemia | 0-20 |
E70.29 | Other disorders of tyrosine metabolism | 0-20 |
E70.30 | Albinism, unspecified | 0-20 |
E70.40 | Disorders of histidine metabolism, unspecified | 0-20 |
E70.41 | Histidinemia | 0-20 |
E70.49 | Other disorders of histidine metabolism | 0-20 |
E70.5 | Disorders of tryptophan metabolism | 0-20 |
E70.81 | Aromatic L-amino acid decarboxylase deficiency | 0-20 |
E70.89 | Other disorders of aromatic amino-acid metabolism | 0-20 |
E71.0 | Maple-syrup-urine disease | 0-20 |
E71.110 | Isovaleric acidemia | 0-20 |
E71.111 | 3-methylglutaconic aciduria | 0-20 |
E71.118 | Other branched-chain organic acidurias | 0-20 |
E71.120 | Methylmalonic acidemia | 0-20 |
E71.121 | Propionic acidemia | 0-20 |
E71.128 | Other disorders of propionate metabolism | 0-20 |
E71.19 | Other disorders of branched-chain amino-acid metabolism | 0-20 |
E71.2 | Disorder of branched-chain amino-acid metabolism, unspecified | 0-20 |
E71.310 | Long chain/very long chain acyl CoA dehydrogenase deficiency | 0-64 |
E71.311 | Medium chain acyl CoA dehydrogenase deficiency | 0-64 |
E71.312 | Short chain acyl CoA dehydrogenase deficiency | 0-64 |
E71.313 | Glutaric aciduria type II | 0-64 |
E71.314 | Muscle carnitine palmitoyltransferase deficiency | 0-64 |
E71.318 | Other disorders of fatty-acid oxidation | 0-64 |
E71.32 | Disorders of ketone metabolism | 0-64 |
E71.39 | Other disorders of fatty-acid metabolism | 0-64 |
E71.41 | Primary carnitine deficiency | 0-64 |
E71.42 | Carnitine deficiency due to inborn errors of metabolism | 0-64 |
E71.50 | Peroxisomal disorder, unspecified | 0-64 |
E71.510 | Zellweger syndrome | 0-64 |
E71.511 | Neonatal adrenoleukodystrophy | 0-64 |
E71.518 | Other disorders of peroxisome biogenesis | 0-64 |
E71.520 | Childhood cerebral X-linked adrenoleukodystrophy | 0-64 |
E71.521 | Adolescent X-linked adrenoleukodystrophy | 0-64 |
E71.522 | Adrenomyeloneuropathy | 0-64 |
E71.528 | Other X-linked adrenoleukodystrophy | 0-64 |
E71.529 | X-linked adrenoleukodystrophy, unspecified type | 0-64 |
E71.53 | Other group 2 peroxisomal disorders | 0-64 |
E71.540 | Rhizomelic chondrodysplasia punctata | 0-64 |
E71.541 | Zellweger-like syndrome | 0-64 |
E71.542 | Other group 3 peroxisomal disorders | 0-64 |
E71.548 | Other peroxisomal disorders | 0-64 |
E72.01 | Cystinuria | 0-20 |
E72.02 | Hartnup's disease | 0-20 |
E72.03 | Lowe's syndrome | 0-20 |
E72.04 | Cystinosis | 0-20 |
E72.09 | Other disorders of amino-acid transport | 0-20 |
E72.11 | Homocystinuria | 0-20 |
E72.12 | Methylenetetrahydrofolate reductase deficiency | 0-20 |
E72.19 | Other disorders of sulfur-bearing amino-acid metabolism | 0-20 |
E72.20 | Disorder of urea cycle metabolism, unspecified | 0-20 |
E72.21 | Argininemia | 0-20 |
E72.22 | Arginosuccinic aciduria | 0-20 |
E72.23 | Citrullinemia | 0-20 |
E72.29 | Other disorders of urea cycle metabolism | 0-20 |
E72.3 | Disorders of lysine and hydroxylysine metabolism | 0-20 |
E72.4 | Disorders of ornithine metabolism | 0-20 |
E72.51 | Non-ketotic hyperglycinemia | 0-20 |
E72.52 | Trimethylaminuria | 0-20 |
E72.53 | Primary hyperoxaluria | 0-20 |
E72.59 | Other disorders of glycine metabolism | 0-20 |
E72.89 | Other specified disorders of amino-acid metabolism | 0-20 |
E74.00 | Glycogen storage disease, unspecified | 0-20 |
E74.01 | von Gierke disease | 0-20 |
E74.02 | Pompe disease | 0-20 |
E74.03 | Cori disease | 0-20 |
E74.04 | McArdle disease | 0-20 |
E74.09 | Other glycogen storage disease | 0-20 |
E74.12 | Hereditary fructose intolerance | 0-20 |
E74.19 | Other disorders of fructose metabolism | 0-20 |
E74.21 | Galactosemia | 0-20 |
E74.29 | Other disorders of galactose metabolism | 0-20 |
E74.4 | Disorders of pyruvate metabolism and gluconeogenesis | 0-20 |
E75.00 | GM2 gangliosidosis, unspecified | 0-20 |
E75.01 | Sandhoff disease | 0-20 |
E75.02 | Tay-Sachs disease | 0-20 |
E75.09 | Other GM2 gangliosidosis | 0-20 |
E75.10 | Unspecified gangliosidosis | 0-20 |
E75.11 | Mucolipidosis IV | 0-20 |
E75.19 | Other gangliosidosis | 0-20 |
E75.21 | Fabry (-Anderson) disease | 0-20 |
E75.22 | Gaucher disease | 0-20 |
E75.23 | Krabbe disease | 0-20 |
E75.242 | Niemann-Pick disease type C | 0-20 |
E75.243 | Niemann-Pick disease type D | 0-20 |
E75.244 | Niemann-Pick disease type A/B | 0-20 |
E75.25 | Metachromatic leukodystrophy | 0-20 |
E75.26 | Sulfatase deficiency | 0-20 |
E75.29 | Other sphingolipidosis | 0-20 |
E75.3 | Sphingolipidosis, unspecified | 0-20 |
E75.4 | Neuronal ceroid lipofuscinosis | 0-20 |
E75.5 | Other lipid storage disorders | 0-20 |
E76.01 | Hurler's syndrome | 0-64 |
E76.02 | Hurler-Scheie syndrome | 0-64 |
E76.03 | Scheie's syndrome | 0-64 |
E76.1 | Mucopolysaccharidosis, type II | 0-64 |
E76.210 | Morquio A mucopolysaccharidoses | 0-64 |
E76.211 | Morquio B mucopolysaccharidoses | 0-64 |
E76.219 | Morquio mucopolysaccharidoses, unspecified | 0-64 |
E76.22 | Sanfilippo mucopolysaccharidoses | 0-64 |
E76.29 | Other mucopolysaccharidoses | 0-64 |
E76.3 | Mucopolysaccharidosis, unspecified | 0-64 |
E76.8 | Other disorders of glucosaminoglycan metabolism | 0-64 |
E77.0 | Defects in post-translational mod of lysosomal enzymes | 0-20 |
E77.1 | Defects in glycoprotein degradation | 0-20 |
E77.8 | Other disorders of glycoprotein metabolism | 0-20 |
E79.1 | Lesch-Nyhan syndrome | 0-64 |
E79.2 | Myoadenylate deaminase deficiency | 0-64 |
E79.8 | Other disorders of purine and pyrimidine metabolism | 0-64 |
E79.9 | Disorder of purine and pyrimidine metabolism, unspecified | 0-64 |
E80.3 | Defects of catalase and peroxidase | 0-64 |
E84.0 | Cystic fibrosis with pulmonary manifestations | 0-64 |
E84.11 | Meconium ileus in cystic fibrosis | 0-64 |
E84.19 | Cystic fibrosis with other intestinal manifestations | 0-64 |
E84.8 | Cystic fibrosis with other manifestations | 0-64 |
E84.9 | Cystic fibrosis, unspecified | 0-64 |
E88.40 | Mitochondrial metabolism disorder, unspecified | 0-64 |
E88.41 | MELAS syndrome | 0-64 |
E88.42 | MERRF syndrome | 0-64 |
E88.49 | Other mitochondrial metabolism disorders | 0-64 |
E88.89 | Other specified metabolic disorders | 0-64 |
F84.2 | Rett's syndrome | 0-20 |
G11.0 | Congenital nonprogressive ataxia | 0-20 |
G11.10 | Early-onset cerebellar ataxia, unspecified | 0-20 |
G11.11 | Friedreich ataxia | 0-20 |
G11.19 | Other early-onset cerebellar ataxia | 0-20 |
G11.2 | Late-onset cerebellar ataxia | 0-20 |
G11.3 | Cerebellar ataxia with defective DNA repair | 0-20 |
G11.4 | Hereditary spastic paraplegia | 0-20 |
G11.8 | Other hereditary ataxias | 0-20 |
G11.9 | Hereditary ataxia, unspecified | 0-20 |
G12.0 | Infantile spinal muscular atrophy, type I (Werdnig-Hoffman) | 0-20 |
G12.1 | Other inherited spinal muscular atrophy | 0-20 |
G12.21 | Amyotrophic lateral sclerosis | 0-20 |
G12.22 | Progressive bulbar palsy | 0-20 |
G12.29 | Other motor neuron disease | 0-20 |
G12.8 | Other spinal muscular atrophies and related syndromes | 0-20 |
G12.9 | Spinal muscular atrophy, unspecified | 0-20 |
G24.1 | Genetic torsion dystonia | 0-64 |
G24.8 | Other dystonia | 0-64 |
G25.3 | Myoclonus | 0-5 |
G25.9 | Extrapyramidal and movement disorder, unspecified | 0-20 |
G31.81 | Alpers disease | 0-20 |
G31.82 | Leigh's disease | 0-20 |
G31.9 | Degenerative disease of nervous system, unspecified | 0-20 |
G32.81 | Cerebellar ataxia in diseases classified elsewhere | 0-20 |
G37.0 | Diffuse sclerosis of central nervous system | 0-64 |
G37.5 | Concentric sclerosis (Balo) of central nervous system | 0-64 |
G71.00 | Muscular dystrophy, unspecified | 0-64 |
G71.01 | Duchenne or Becker muscular dystrophy | 0-64 |
G71.02 | Facioscapulohumeral muscular dystrophy | 0-64 |
G71.031 | Autosomal dominant limb girdle muscular dystrophy | 0-64 |
G71.032 | Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction | 0-64 |
G71.033 | Limb girdle muscular dystrophy due to dysferlin dysfunction | 0-64 |
G71.0340 | Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified | 0-64 |
G71.0341 | Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction | 0-64 |
G71.0342 | Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction | 0-64 |
G71.0349 | Limb girdle muscular dystrophy due to other sarcoglycan dysfunction | 0-64 |
G71.035 | Limb girdle muscular dystrophy due to anoctamin-5 dysfunction | 0-64 |
G71.038 | Other limb girdle muscular dystrophy | 0-64 |
G71.039 | Limb girdle muscular dystrophy, unspecified | 0-64 |
G71.09 | Other specified muscular dystrophies | 0-64 |
G71.11 | Myotonic muscular dystrophy | 0-64 |
G71.20 | Congenital myopathy, unspecified | 0-64 |
G71.21 | Nemaline myopathy | 0-64 |
G71.220 | Centronuclear myopathy | 0-64 |
G71.228 | Other centronuclear myopathy | 0-64 |
G71.29 | Other congenital myopathy | 0-64 |
G80.0 | Spastic quadriplegic cerebral palsy | 0-64 |
G80.1 | Spastic diplegic cerebral palsy | 0-20 |
G80.3 | Athetoid cerebral palsy | 0-64 |
G82.50 | Quadriplegia, unspecified | 0-64 |
G82.51 | Quadriplegia, C1-C4 complete | 0-64 |
G82.52 | Quadriplegia, C1-C4 incomplete | 0-64 |
G82.53 | Quadriplegia, C5-C7 complete | 0-64 |
G82.54 | Quadriplegia, C5-C7 incomplete | 0-64 |
G91.0 | Communicating hydrocephalus | 0-20 |
G91.1 | Obstructive hydrocephalus | 0-20 |
I67.5 | Moyamoya disease | 0-64 |
K91.2 | Postsurgical malabsorption, not elsewhere classified | 0-20 |
N03.A | Chronic nephritic syndrome with C3 glomerulonephritis | 0-20 |
N03.1 | Chronic nephritic syndrome with focal and segmental glomerular lesions | 0-20 |
N03.2 | Chronic nephritic syndrome w diffuse membranous glomrlneph | 0-20 |
N03.3 | Chronic neph syndrome w diffuse mesangial prolif glomrlneph | 0-20 |
N03.4 | Chronic neph syndrome w diffuse endocaplry prolif glomrlneph | 0-20 |
N03.5 | Chronic nephritic syndrome w diffuse mesangiocap glomrlneph | 0-20 |
N03.6 | Chronic nephritic syndrome with dense deposit disease | 0-20 |
N03.7 | Chronic nephritic syndrome w diffuse crescentic glomrlneph | 0-20 |
N03.8 | Chronic nephritic syndrome with other morphologic changes | 0-20 |
N03.9 | Chronic nephritic syndrome with unsp morphologic changes | 0-20 |
N08 | Glomerular disorders in diseases classified elsewhere | 0-20 |
N18.1 | Chronic kidney disease, stage 1 | 0-20 |
N18.2 | Chronic kidney disease, stage 2 (mild) | 0-20 |
N18.30 | Chronic kidney disease, stage 3, unspecified | 0-20 |
N18.31 | Chronic kidney disease, stage 3a | 0-20 |
N18.32 | Chronic kidney disease, stage 3b | 0-20 |
N18.4 | Chronic kidney disease, stage 4 (severe) | 0-20 |
N18.5 | Chronic kidney disease, stage 5 | 0-20 |
N18.6 | End stage renal disease | 0-20 |
N18.9 | Chronic kidney disease, unspecified | 0-20 |
Q01.9 | Encephalocele, unspecified | 0-20 |
Q02 | Microcephaly | 0-20 |
Q03.0 | Malformations of aqueduct of Sylvius | 0-20 |
Q03.1 | Atresia of foramina of Magendie and Luschka | 0-20 |
Q03.8 | Other congenital hydrocephalus | 0-20 |
Q03.9 | Congenital hydrocephalus, unspecified | 0-20 |
Q04.3 | Other reduction deformities of brain | 0-20 |
Q04.5 | Megalencephaly | 0-20 |
Q04.6 | Congenital cerebral cysts | 0-20 |
Q04.8 | Other specified congenital malformations of brain | 0-20 |
Q05.0 | Cervical spina bifida with hydrocephalus | 0-64 |
Q05.1 | Thoracic spina bifida with hydrocephalus | 0-64 |
Q05.2 | Lumbar spina bifida with hydrocephalus | 0-64 |
Q05.3 | Sacral spina bifida with hydrocephalus | 0--64 |
Q05.4 | Unspecified spina bifida with hydrocephalus | 0-64 |
Q05.5 | Cervical spina bifida without hydrocephalus | 0-64 |
Q05.6 | Thoracic spina bifida without hydrocephalus | 0-64 |
Q05.7 | Lumbar spina bifida without hydrocephalus | 0-64 |
Q05.8 | Sacral spina bifida without hydrocephalus | 0-64 |
Q05.9 | Spina bifida, unspecified | 0-64 |
Q06.0 | Amyelia | 0-64 |
Q06.1 | Hypoplasia and dysplasia of spinal cord | 0-64 |
Q06.2 | Diastematomyelia | 0-64 |
Q06.3 | Other congenital cauda equina malformations | 0-64 |
Q06.4 | Hydromyelia | 0-64 |
Q06.8 | Other specified congenital malformations of spinal cord | 0-64 |
Q07.01 | Arnold-Chiari syndrome with spina bifida | 0-64 |
Q07.02 | Arnold-Chiari syndrome with hydrocephalus | 0-64 |
Q07.03 | Arnold-Chiari syndrome with spina bifida and hydrocephalus | 0-64 |
Q30.1 | Agenesis and underdevelopment of nose, cleft or absent nose only | 0-5 |
Q30.2 | Fissured, notched and cleft nose, cleft or absent nose only | 0-5 |
Q31.0 | Web of larynx | 0-20 |
Q31.8 | Other congenital malformations of larynx, atresia or agenesis of larynx only | 0-20 |
Q32.1 | Other congenital malformations of trachea, atresia or agenesis of trachea only | 0-20 |
Q32.4 | Other congenital malformations of bronchus, atresia or agenesis of bronchus only | 0-20 |
Q33.0 | Congenital cystic lung | 0-20 |
Q33.2 | Sequestration of lung | 0-20 |
Q33.3 | Agenesis of lung | 0-20 |
Q33.6 | Congenital hypoplasia and dysplasia of lung | 0-20 |
Q35.1 | Cleft hard palate | 0-20 |
Q35.3 | Cleft soft palate | 0-20 |
Q35.5 | Cleft hard palate with cleft soft palate | 0-20 |
Q35.9 | Cleft palate, unspecified | 0-20 |
Q37.0 | Cleft hard palate with bilateral cleft lip | 0-20 |
Q37.1 | Cleft hard palate with unilateral cleft lip | 0-20 |
Q37.2 | Cleft soft palate with bilateral cleft lip | 0-20 |
Q37.3 | Cleft soft palate with unilateral cleft lip | 0-20 |
Q37.4 | Cleft hard and soft palate with bilateral cleft lip | 0-20 |
Q37.5 | Cleft hard and soft palate with unilateral cleft lip | 0-20 |
Q37.8 | Unspecified cleft palate with bilateral cleft lip | 0-20 |
Q37.9 | Unspecified cleft palate with unilateral cleft lip | 0-20 |
Q39.0 | Atresia of esophagus without fistula | 0-3 |
Q39.1 | Atresia of esophagus with tracheo-esophageal fistula | 0-3 |
Q39.2 | Congenital tracheo-esophageal fistula without atresia | 0-3 |
Q39.3 | Congenital stenosis and stricture of esophagus | 0-3 |
Q39.4 | Esophageal web | 0-3 |
Q42.0 | Congenital absence, atresia and stenosis of rectum with fistula | 0-5 |
Q42.1 | Congen absence, atresia and stenosis of rectum without fistula | 0-5 |
Q42.2 | Congenital absence, atresia and stenosis of anus with fistula | 0-5 |
Q42.3 | Congenital absence, atresia and stenosis of anus without fistula | 0-5 |
Q42.8 | Congenital absence, atresia and stenosis of other parts of large intestine | 0-5 |
Q42.9 | Congenital absence, atresia and stenosis of large intestine, part unspecified | 0-5 |
Q43.1 | Hirschsprung's disease | 0-15 |
Q44.2 | Atresia of bile ducts | 0-20 |
Q44.3 | Congenital stenosis and stricture of bile ducts | 0-20 |
Q44.6 | Cystic disease of liver | 0-20 |
Q45.0 | Agenesis, aplasia and hypoplasia of pancreas | 0-5 |
Q45.1 | Annular pancreas | 0-5 |
Q45.3 | Other congenital malformations of pancreas and pancreatic duct | 0-5 |
Q45.8 | Other specified congenital malformations of digestive system | 0-10 |
Q60.1 | Renal agenesis, bilateral | 0-20 |
Q60.4 | Renal hypoplasia, bilateral | 0-20 |
Q60.6 | Potter's syndrome, with bilateral renal agenesis only | 0-20 |
Q61.02 | Congenital multiple renal cysts, bilateral only | 0-20 |
Q61.19 | Other polycystic kidney, infantile type, bilateral only | 0-20 |
Q61.2 | Polycystic kidney, adult type, bilateral only | 0-20 |
Q61.3 | Polycystic kidney, unspecified, bilateral only | 0-20 |
Q61.4 | Renal dysplasia, bilateral only | 0-20 |
Q61.5 | Medullary cystic kidney, bilateral only | 0-20 |
Q61.9 | Cystic kidney disease, unspecified, bilateral only | 0-20 |
Q64.10 | Exstrophy of urinary bladder, unspecified | 0-20 |
Q64.12 | Cloacal extrophy of urinary bladder | 0-20 |
Q64.19 | Other exstrophy of urinary bladder | 0-20 |
Q75.0 | Craniosynostosis | 0-20 |
Q75.1 | Craniofacial dysostosis | 0-20 |
Q75.2 | Hypertelorism | 0-20 |
Q75.4 | Mandibulofacial dysostosis | 0-20 |
Q75.5 | Oculomandibular dysostosis | 0-20 |
Q75.8 | Other congenital malformations of skull and face bones | 0-20 |
Q77.4 | Achondroplasia | 0-1 |
Q77.6 | Chondroectodermal dysplasia | 0-1 |
Q77.8 | Other osteochondrodysplasia with defects of growth of tubular bones and spine | 0-1 |
Q78.0 | Osteogenesis imperfecta | 0-20 |
Q78.1 | Polyostotic fibrous dysplasia | 0-1 |
Q78.2 | Osteopetrosis | 0-1 |
Q78.3 | Progressive diaphyseal dysplasia | 0-1 |
Q78.4 | Enchondromatosis | 0-1 |
Q78.6 | Multiple congenital exostoses | 0-1 |
Q78.8 | Other specified osteochondrodysplasias | 0-1 |
Q78.9 | Osteochondrodysplasia, unspecified | 0-1 |
Q79.0 | Congenital diaphragmatic hernia | 0-1 |
Q79.1 | Other congenital malformations of diaphragm | 0-1 |
Q79.2 | Exomphalos | 0-1 |
Q79.3 | Gastroschisis | 0-1 |
Q79.4 | Prune belly syndrome | 0-1 |
Q79.59 | Other congenital malformations of abdominal wall | 0-1 |
Q89.7 | Multiple congenital malformations, not elsewhere classified | 0-10 |
R75 | Inconclusive laboratory evidence of HIV | 0-12 months |
Z21 | Asymptomatic human immunodeficiency virus infection status | 0-20 |
Z99.11 | Dependence on respirator (ventilator) status | 1-64 |
Z99.2 | Dependence on renal dialysis | 21-64 |
Md. Code Regs. 10.09.69.17
Regulations .17 adopted effective March 10, 1997 (24:5 Md. R. 408)
Regulations .17 repealed and new
Regulations .17 adopted effective February 2, 2004 (31:2 Md. R. 84)
Regulation .17 amended effective November 5, 2007 (34:22 Md. R. 1977); June 30, 2008 (35:13 Md. R. 1180); October 5, 2009 (36:20 Md. R. 1528); December 27, 2010 (37:26 Md. R. 1787); December 24, 2012 (39:25 Md. R. 1613)
Regulation .17 amended effective 42:21 Md. R. 1301, eff.10/26/2015; recodified from .16 effective 45:13 Md. R. 665, eff. 7/2/2018; amended effective 46:10 Md. R. 485, eff. 5/20/2019; amended effective 49:23 Md. R. 995, eff. 11/14/2022; amended effective 50:23 Md. R. 1004, eff. 11/27/2023